Autosomic dominant polycystic kidney disease and metformin: Old knowledge and new insights on retarding progression of chronic kidney disease-Reference-Cited by-同舟云学术

Autosomic dominant polycystic kidney disease and metformin: Old knowledge and new insights on retarding progression of chronic kidney disease

Published:2021-07-30 Issue:1 Volume:42 Page:629-640
ISSN:0198-6325
Container-title:Medicinal Research Reviews
language:en
Short-container-title:Med Res Rev

Author:

Casarella Alessandro¹,Nicotera Ramona²,Zicarelli Maria T.²,Urso Alessandra²,Presta Pierangela²,Deodato Francesca²,Bolignano Davide²,De Sarro Giovambattista¹,Andreucci Michele²,Russo Emilio¹,Coppolino Giuseppe²^ORCID

Affiliation:

1. Department of Health Sciences “Magna Graecia” University Catanzaro Italy

2. Department of Health Sciences, Renal Unit “Magna Graecia” University Catanzaro Italy

Publisher

Wiley

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/med.21850

Reference40 articles.

1. Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2016

2. Autosomal dominant polycystic kidney disease

3. Polycystins and partners: proposed role in mechanosensitivity

4. Autosomal dominant polycystic kidney disease: Disrupted pathways and potential therapeutic interventions

5. Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferroptosis as a molecular target of epigallocatechin gallate in diseases;Archives of Physiology and Biochemistry;2024-09-12

2. Metformin Protects Against Acute Kidney Injury Induced by Lipopolysaccharide via Up-Regulating the MCPIP1/SIRT1 Pathway;Biochemical Genetics;2024-02-12

3. Extensive therapeutic effects, underlying molecular mechanisms and disease treatment prediction of Metformin: a systematic review;Translational Research;2024-01

4. Metformin as an activator of AMP-activated protein kinase. Known and new mechanisms of action;Diabetes mellitus;2023-09-25

5. Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer;Signal Transduction and Targeted Therapy;2023-05-19